We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 253

Putative class alleges pharma statements about new drug violated securities laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

Athletic training supplement allegedly fails to deliver benefits

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

A California resident has filed consumer fraud claims against the Vitamin Shoppe, Inc., on behalf of a putative statewide class of individuals who

Genetic technologies settles infringement suit over non-DNA coding technology

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms

Brazilian regulator fines Mcdonald’s over Happy Meal promotion

  • Shook Hardy & Bacon LLP
  • -
  • Brazil
  • -
  • April 26 2013

The consumer regulatory agency of Sao Paulo, Brazil, has reportedly fined McDonald's US$1.6 million for allegedly marketing to children. Procon SP

FDA consent decree addresses dietary supplement maker’s manufacturing practices

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 25 2013

A federal court in New York has entered a consent decree of permanent injunction against Kabco Pharmaceuticals, Inc. and its CEO to enjoin them from

SCOTUS hears arguments on patentability of human genes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 18 2013

The U.S. Supreme Court (SCOTUS) heard arguments on Monday specifically addressing whether "human genes are patentable." Ass'n for Molecular Pathology

Dietary supplement class stayed pending settlement in related litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 11 2013

Because a virtually identical class action pending before a state court is near settlement, a federal court in California has agreed, in the interest

Ninth Circuit to consider impact of trial court error in admitting expert testimony

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 4 2013

In related cases that could have implications for intellectual property, consumer safety and complex litigation where resolution of the dispute

Indian Supreme Court rules Novartis cancer drug change not patentable

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • April 4 2013

The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy